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Introduction: Cell-based therapy was a promising treatment method for disc degenerative diseases. Wharton’s jelly
cell (WJC) has been explored to cure various human diseases, while it still remains unknown about this MSC for disc
repair. In our prior work, WJCs could differentiate into nucleus pulposus (NP)-like cells by co-culturing with NP cells
in vitro. Thence, the aim of this study was further to investigate the survival and function of WJCs in vivo after
transplantation into degenerated canine discs.
Method: WJCs were isolated from human umbilical cords and labeled with EGFP. The degeneration of L4-5, L5-6,
and L6-7 discs of beagles was induced by aspirating the NP tissues. Four weeks after the operation, the injured
discs were left to be no treatment at L4-5 (DS group), injected with 0.9 % saline at L5-6 (FS group), and
transplanted with EGFP-labeled WJCs at L6-7 (TS group). In all animals, the intact disc L3-4 served as a control
(CS group). The animals were followed up for 24 weeks after initial operation. Spine imaging was evaluated at
4, 8, 12, and 24 weeks, respectively. Histologic, biomechanics and gene expression analyses were performed at
24 weeks. Immunohistochemistry for aggrecan, types II collagen, SOX-9 was employed to investigate the matrix
formation in the NP.
Results: The TS group showed a significantly smaller reduction in the disc height and T2-weighted signal intensity,
and a better spinal segmental stability than DS and FS groups. Histologic assay demonstrated that WJCs were
specifically detected in TS group at 24 weeks and the discs of TS group maintained a relatively well preserved structure
as compared to the discs of DS and FS groups. Furthermore, real-time PCR and immunohistochemistry demonstrated
that expressions of disc matrix genes, aggrecan, type II collagen, and SOX-9, were up-regulated in TS group compared
to DS and FS groups.
Conclusion: WJCs could not only survive in the degenerate IVDs, but also promote the disc matrix formation of aggrecan
and type II collagen in the degenerate IVDs. It may have value in cell-based therapy for degenerative disc disease.Introduction
Chronic low back pain (LBP) is one of the most common
musculoskeletal disorders in humans. Intervertebral disc
(IVD) degeneration and associated pathology have been
implicated as a major cause of LBP [1]. Studies have
revealed that the nucleus pulposus (NP) of the IVD played
a prominent role in both the onset and progression of* Correspondence: Ruandikengh@163.com
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article, unless otherwise stated.IVD degeneration, which was characterized by the loss of
cells in NP and followed by decreased function of produ-
cing extracellular matrix (ECM) [2–4]. Current treatment
for degenerative disc disease is usually limited to conser-
vative and invasive care, including nonsurgical modalities
and operative methods. None of these treatment strategies
produce reliable outcomes, however, because their aim
was only to relieve acute symptoms and they failed to
promote tissue regeneration or halt the process of IVD
degeneration. In response to this challenge, it is of great
significance to develop novel technologies to manage IVDle is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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ising treatment method for degenerative disc disease.
The lack of ideal exogenous cells, however, remains a
serious problem among the methods. In recent years,
many cell sources such as autologous NP cells have
been evaluated to promote IVD tissue regeneration [5].
But human NP tissues contain few healthy autologous
cells except a small quantity of NP progenitor cells [6].
Alternatively, mesenchymal stem cells (MSCs) have
been explored as a promising cell source for repairing
degenerate IVD [7–9]. MSCs are multipotent stem cells
that can be isolated, expanded, and stimulated to differen-
tiate into a variety of cells, including osteoblasts, chondro-
cytes, myocytes, adipocytes, and beta pancreatic islet cells
[10, 11]. Studies have shown that MSCs could be induced
to differentiate into an NP-like phenotype when stimu-
lated appropriately [12–15]. MSCs can also be injected
directly, or together with a scaffold, into the degenerate
IVD, where they can differentiate into disc cells, produce
ECM, and reestablish healthy disc function [16, 17].
Taking these results together, MSCs have been highlighted
as a potential therapeutic option for the IVD regenerative
medicine.
MSCs are widely distributed in a variety of human tis-
sues such as fetal liver, umbilical cord, bone marrow, adi-
pose tissue, joint synovia, muscle, and dermis. Although
bone marrow represents the main source of MSCs for
both experimental and clinical studies, the number and
the proliferative/differentiation capacity of bone marrow
MSCs (BMSCs) significantly decrease with age [18, 19].
Thus, it is necessary to look for possible alternative
sources of MSCs. Human umbilical cord Wharton’s
jelly tissue is one such alternative and contains stem
cells similar to adult MSCs [20, 21]. These cells, known
as Wharton’s jelly cells (WJCs), could self-renew and
differentiate into various cell types [22], such as cardio-
myocytogenic cells, muscle cells [23], osteogenic cells
[24, 25], adipogenic cells [26], and neural cells [27–29].
WJCs also have been explored to cure various human
diseases [30, 31] such as cancer [32], liver disease [33],
cartilage injuries [34], cardiovascular disease [35], skin
wounds [36], osteoarthritis [37], obesity [38], and dia-
betes [39]. Furthermore, WJCs have also been proposed
as a potential application in connective tissue repair
[40] and even degenerative disc disease. One study has
demonstrated that WJCs could differentiate into cells
with an immature NP-like phenotype under suitable
environmental conditions [41]. Our earlier study also
found that WJCs could differentiate into NP-like cells by
coculturing with the NP cells and induce the disc matrix
formation [42]. Furthermore, in a direct cell-to-cell con-
tact condition, WJCs could upregulate the expression of
the disc matrix aggrecan, type II collagen, and SRY-box 9
(SOX-9), suggesting that the direct cell–cell contact wasimportant for WJC differentiation. Above all, these studies
propose that WJCs might be promising seed cells in cell-
based treatment for degenerative disc disease. This study
was therefore conducted to explore the potential of WJC
implantation to restore degenerate IVD. We used imaging
and histological analyses to investigate survival and regen-
erative effects of WJCs after transplantation into the de-
generate IVDs in a canine disc degeneration model.Materials and methods
Wharton’s jelly cell isolation, culture, and flow cytometry
analysis
This study was approved by the Navy General Hospital
Ethical Committee. With the consent of the parents,
human umbilical cord Wharton’s jelly was collected
from infants delivered by full-term normal labor. The
cells from the Wharton's jelly tissue were isolated as de-
scribed previously [26]. Briefly, after removal of blood ves-
sels and epithelium, the Wharton’s jelly was cut into
pieces about 1.5–2.5 mm3, and digested for 18 hours at
37 °C with 0.2 mg/ml collagenase (Sigma St. Louis,
Missouri, USA) solution in serum-free medium containing
100 U/ml penicillin, 100 mg/ml streptomycin, and
2.5 mg/ml amphotericin B. The isolated cells were sus-
pended in Dulbecco's modified Eagle’s medium (DMEM)/
F12 nutrient mixture containing 20 % fetal bovine serum
(FBS). When WJCs were cultured to reach 80–90 %
confluence, they were passaged and seeded at a density of
4 × 103/cm2 in DMEM/F12 with 10 % FBS. WJCs at pas-
sage 3 were taken for flow cytometry analysis as described
previously [42]. The antibodies used were phycoerythrin
(PE)-conjugated CD105, CD73, CD45, CD29, CD166, hu-
man leukocyte antigen (HLA)-DR, HLA-ABC, and fluor-
escein isothiocyanate (FITC)-conjugated CD34 and CD90
(all eBioscience, Santiago, California, USA).Transfection of Wharton’s jelly cells with AAV2-EGFP viral
vector
To facilitate analysis of the survival of transplanted
WJCs in the NP region, the WJCs were infected with
AAV2-EGFP, an adeno-associated virus vector express-
ing the enhanced green fluorescent protein (EGFP)
gene. Briefly, after the third passage, the cells were cul-
tured in 25 cm culture flasks until reaching 80 % conflu-
ence. The cells were then washed with phosphate-buffered
saline (PBS; Gibco Grand Island, New York, USA) and in-
fected with AAV2-EGFP at multiplicity of infection 105
vector genome/cell. Noninfected cells served as a negative
control. The cells were incubated for 1 hour, washed in
PBS, and cultured in DMEM/F12 with 10 % FBS. After
5 days, green fluorescent protein (GFP) expression was
observed using a fluorescence microscope, and vector in-
corporation was tested by flow cytometry.
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Wharton’s jelly cells
Eighteen skeletal mature beagles (11–13 months old),
weighing approximately 10 kg, were used in this study.
Animal experiments were approved by Navy General
Hospital Animal Experimentation Committee. All ani-
mals were healthy and free of infection, and were given
X-ray and magnetic resonance imaging (MRI) scans of
the spine to assure the absence of IVD degeneration-
related diseases before the study. Surgical procedures
were performed under general anesthesia by intramus-
cular administration of ketamine hydrochloride injec-
tion (0.1 ml/kg) and xylazine hydrochloride (0.08 ml/
kg). The anterior surfaces of three consecutive lumbar
discs (L4–5, L5–6, and L6–7) were exposed through an
anterior–lateral approach. To induce disc degeneration,
an 18-gauge needle was inserted at the center of the
disc through the annulus fibrosus (AF) into the NP.
The NP was then aspirated using a 10 ml syringe, as
described previously [43, 44]. The mean weight of the
NP aspirated from a single disc was 14.5 ± 2.7 mg. Four
weeks after the operation, the injured disc L4–5 remained
with no treatment as a degenerative segment (DS group),
the injured disc L5–6 was injected with 100 μl of 0.9 %
saline (FS group), and the injured disc L6–7 was trans-
planted with 100 μl of 1 × 106 EGFP-labeled WJCs (TS
group). In all animals, the intact L3–4 disc served as a
noninjured control (CS group). The animals were followed
up for 24 weeks after the initial operation. The changes in
the lumbar discs were assessed using radiographs, MRI,
biomechanical testing, (immuno)histology, and gene ex-
pression analysis.
Radiological analysis of disc height
Lateral radiographs were taken at 0, 4, 8, 12, and 24 weeks.
A fluoroscopic imaging intensifier (radiographs; 68 kV,
10 mA, 100 cm distance) was used. The digitized radio-
graphic images were stored and evaluated using the
CDmanager software program (version 6.5.0.0; Silver
MedInfo. Tech., Beijing, China). The measurements in-
cluded vertebral body height and IVD height. The disc
height index (DHI) at each level was determined based
on the method of Lu et al. [45]. Changes in the DHI
were expressed as %DHI and normalized to the mea-
sured preoperative IVD height:
%DHI ¼ postoperative DHI=preoperative DHIð Þ  100ð Þ:
Magnetic resonance imaging
MRI scans were taken to evaluate signal changes in T2-
weighted images at 0, 4, 8, 12, and 24 weeks after the
first operation in all groups. MRI scans were obtained in
T2-weighted images in all groups at each time point inthe sagittal and axial planes using a 1.5 T scanner
(Magneton 63P/4000; Siemens, Iselin, NJ, USA). T2-
weighted sections in the sagittal plane were obtained
under the following settings: fast spin echo sequence
with time to repetition of 2500 seconds and time to
echo of 85 seconds; 384 (h) × 224 (v) matrix; field of
view of 260; and four excitations. The section thickness
was 3 mm with a 0.3 mm gap. The digitized MRI scans
were stored on computer, and the CDmanager software
program was used to determine the grayscale of the NP
and the cerebrospinal fluid at the same level on a T2-
weighted sagittal MRI scan. The disc relative gray index
(RGI) was calculated by dividing the gray value of the
NP by the gray value of the cerebrospinal fluid. The
MRI scans were also evaluated using the Pfirrmann
classification before and 24 weeks after the first operation
[46–48]. Three observers, blinded to this study, performed
the measurements and grading for radiological and MRI
scans. The means of these measurements were taken, and
the average grade of the three observers was used as the
final grade for each disc. The intraobserver reliability
based on readings at two time intervals 1 month apart
was κ = 0.92, showing an excellent agreement.
Biomechanical analysis
At 24 weeks, all beagles were killed with an excess dose of
ketamine hydrochloride and xylazine hydrochloride injec-
tion, and the 18 spines were harvested. Biomechanical
testing was performed on the spinal motion segment with
all ligamentous attachments and all of the muscles re-
moved. The spinal column was embedded in denture base
resin, with the L3–7 vertebral body remaining outside.
Every vertebra of L3–7 was marked by markers in the
same position (the specific position of every vertebra), and
two video cameras recorded the motion of the markers
from different direction when the biomechanical test was
being carried out. The biomechanical analysis was per-
formed using a biomechanical machine (MTS 858 Mini
Bionix II; Minneapolis, Minnesota, USA). The fresh spinal
specimens were kept wet during the process of testing.
Before carrying out the test, a preliminary load was
stressed on the specimen to reduce the interference from
the viscoelasticity of the specimen. The pre experiment
was repeated five times (30 seconds each time) with 1 N
preloading. To determine the multidirectional flexibility
properties, the multidirectional unconstrained bending
moments (flexion and extension (±3 N m, x axis), left and
right torsion (±3 N m, y axis), and left and right bending
(±3 N m, z axis)) were applied to the superior end of the
vertically oriented specimen, while the caudal portion of
the specimen remained fixed to a testing platform. As the
sample was loaded, the motions of all markers were re-
corded by two video cameras. The multidirectional range
of motion (ROM) of individual motion segments of every
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The ROM was measured five times respectively and the
mean ROM was used for the statistical analysis.
Macroscopic observations and assessment of survival
transplanted Wharton’s jelly cells
After the biomechanical testing, the L3–4/L4–5/L5–6/
L6–7 discs were isolated intact, preserving the bilateral
cartilage endplate and some vertebral body. The discs
from one dog were cut coronally at the center of the
disc for macroscopic evaluation. The discs from an-
other dog were used to identify the surviving injected
cells in the NP tissues. The NP tissue was separated
from the disc and was frozen in tissue-freezing medium
(Fisher Scientific, Pittsburgh, PA, USA) and sectioned
60 μm thick in a transverse plane from each disc. The
GFP-positive cells were observed under fluorescence mi-
croscopy using a Texas Red filter (Chroma, Rockingham,
VT, USA).
Histological and immunohistochemical analysis
The remaining discs of 16 dogs were cut transversally at
the center of the NP. One half of every disc was used for
histological studies, and the other half was used for real-
time PCR analysis of gene expression.
The NP tissues were isolated immediately and were
fixed in 10 % neutral-buffered formalin for 72 hours and
processed for paraffin embedding and cut into transversal
sections (6 μm thick) using a microtome. The sections
were stained with hematoxylin and eosin for evaluation.
Immunohistochemical detection of GFP, type II colla-
gen, aggrecan, and SOX-9 was performed using formalin-
fixed sections obtained as described above. Briefly, NP
tissue sections were maintained at room temperature for
60 minutes and dewaxed by xylene twice (10 minutes
each time). The tissues were then rehydrated by a series
of 5-minute washed in 100 %, 95 %, 80 %, and 70 %
ethanol, followed by 5-minute washed in distilled water
and three consecutive 3-minute washed with PBS. After
inactivating the endogenous peroxidase by incubating
in 3 % hydrogen peroxide for 10 minutes, antigen re-
trieval was performed by heating the samples at 95 °C
for 20 minutes in 10 mM sodium citrate (pH 6.0). After
nonspecific binding was blocked by incubating with
10 % normal goat serum (Solarbio Company, Beijing,
China) for 20 minutes, the NP tissue sections were labeled
overnight at 4 °C with primary antibody: anti-GFP (1:100
dilution), anti-type II collagen (1:200 dilution), anti-
aggrecan (1:100 dilution), and anti-SOX-9 (1:50 dilu-
tion) polyclonal antibodies (immunoglobulin G) (Santa
Cruz Biotech, Santa Cruz, CA, USA). These primary
antibodies were not specific for human, and could also
be reactive with additional species including canine and
porcine. The NP sections were then incubated for60 minutes each with a horseradish peroxidase-labeled
secondary antibody and then streptavidin–peroxidase
(Santa Cruz Biotech). After washing with PBS, the sec-
tions were incubated with 3,30-diaminobenzidine sub-
strate until a brown color developed. Finally, the sections
were counterstained with hematoxylin. The slides were
then dehydrated by a series of 2-minute washes in 50 %,
70 %, 95 %, 95 %, and 100 % ethanol. After two conse-
quent 2-minute washes with xylene, the slides were sealed
with coverslips. Cartilage of the femoral head of the beagle
served as a positive control, and the negative control in-
cluded the use of PBS instead of primary antibody, with
all other conditions kept the same. To quantify the im-
munohistochemical results, staining intensity was ana-
lyzed using the Image-Pro Plus 6.0 (Media Cybernetics,
Rockville, Maryland, USA). The area of interest in all
sections was analyzed, and the mean density was calcu-
lated by integrated optical density divided by the area.Real-time PCR analysis of gene expression
Total RNA was extracted from the NP using the Trizol
reagent (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. RNA was reverse transcribed
into cDNA using AMV reverse transcriptase (Takara Bio-
technology, Dalian, China). After the cDNA had been ob-
tained by reverse transcription, relative gene expressions
of aggrecan, type I collagen, type II collagen, and SOX-9
were determined by real-time PCR and normalized to the
glyceraldehyde-3-phosphate dehydrogenase housekeeping
gene. These primers were designed using Primer Premier
6.0 software (PREMIER Biosoft, palo alto, California, USA)
(Table 1). The Mini Opticon™ Detector System (Bio-Rad,
Hercules, California, USA) and the SYBR Green PCR kit
(Takara Biotechnology, Dalian, China) were used for real-
time PCR analysis. The real-time PCR consisted of an ini-
tial enzyme activation step at 95 °C for 20 seconds,
followed by 40 cycles of 95 °C for 5 seconds and 60 °C for
20 seconds. A cycle threshold (Ct) value was obtained for
each sample, and triplicate sample values were averaged.
The 2–ΔΔCt value was then used to calculate relative ex-
pression of each target gene [49]. The data presented
(mean) were from three independent experiments in which
both sample sets were analyzed in triplicate.Statistical analysis
SPSS version 15.0 software (Chicago, Illinois, USA) was
used for statistical analysis. The comparison of group
means between the CS group, the TS group, the FS group,
and the DS group was determined using repeated-measure
analysis of variance and Fisher’s least significant difference
post-hoc test, in which p <0.05 was considered significant.
The Mann–Whitney U test was used to analyze the non-
parametric data from MRI Pfirrmann grading.
Table 1 Primers designed using Primer Premier 6.0 software
Gene Gene bank Sequence
Type II collagen NM_001006951.1 5′-GAAGAGCGGAGACTACTGGATTG-3′
5′-AGGCGGAGGAAGGTCATCTG-3′








Primer Premier 6.0 software from PREMIER Biosoft (palo alto, California, USA)
GAPDH glyceraldehyde-3-phosphate dehydrogenase, SOX-9 SRY-box 9
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Characterization of Wharton’s jelly cells and expression of
cell surface receptors and green fluorescent protein in
WJCs
The primary WJCs in vitro displayed adherent growth
and could form cell colonies (Fig. 1a). The subculturedFig. 1 Morphology of human WJCs and expression of GFP in WJCs. a After
enzyme-digested Wharton’s jelly tissues and adhered to the culture dish, a
in culture, passage 3 Wharton’s jelly MSCs appeared to be mostly spindle-s
expressing EGFP with multiplicity of infection (MOI) of 1 × 105 vector gen
EGFP infection (bar = 50 μm). EGFP enhanced green fluorescent proteinWJCs exhibited fibroblast-like morphology and uniform
distribution in the tissue culture plastic surface (Fig. 1b).
Flow cytometric analysis showed that the cells expressed
CD90, CD73, CD105, CD29, and HAL-ABC, but were
negative for CD34, CD45, and HLA-DR (Table 2). GFP ex-
pression was confirmed using a fluorescence microscopeinitial culturing for 3 days, fibroblast-like cells migrated out from the
nd the fibroblastic colony formation could be observed. b After 3 days
haped or triangular. c Fluorescent imaging of WJCs infected with AAV2
ome/cell. d Vector incorporation was 79.7 % at 5 days after AAV2-
Table 2 Human Wharton’s jelly cells of passage 3 express cell
surface markers typical to mesenchymal stem cells










Values represent a mean of triple samples (n = 3). Data obtained via flow
cytometry analysis
aPercentage of total number of cells expressing the markers
HLA human leukocyte antigen, MFI mean fluorescence intensity
Fig. 2 Radiographic assessment. a Representative radiographic images from
(FS and DS groups), and intact disc group (CS group) at 0, 4, 8, 12, and 24 we
quantify changes in disc height. Note: %DHI in the TS group was significantly
24 weeks after the first operation. Each data point represents the mean and s
disc height index
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corporation was 79.7 % using flow cytometric analysis
(Fig. 1d).
Changes in the intervertebral disc height
We first evaluated the effect of WJC transplantation on the
disc height. At 4 weeks after the initial operation, narrow-
ing of the disc space was observed in all three operated
groups (DS, FS, and TS groups). The %DHI of the DS and
FS groups continued to decrease in the entire experimental
period. The %DHI of the TS group also decreased grad-
ually over time but was higher than that of the DS and FS
groups at 8, 12, and 24 weeks (p <0.05) (Fig. 2).
Magnetic resonance imaging assessment
As shown in Fig. 3, the mean RGI of the CS group barely
changed throughout the study. The mean RGI in the DS,
FS, and TS groups showed a significant decrease after thethe WJC transplanted group (TS group), degenerated control groups
eks after the first operation. b %DHI was measured at each time point to
higher than those of the discs in the FS and DS groups at 8, 12, 18, and
tandard deviation of 18 samples (*p <0.05, n = 18). %DHI changes in the
Fig. 3 MRI analysis. a Representative MRI scans of the discs from the WJC transplanted group (TS group), degenerated control groups (FS and DS
groups), and intact disc group (CS group) at 0, 4, 8, 12, and 24 weeks after the first operation. b Disc relative gray index (RGI) at 0, 4, 8, 12, 18, and
24 weeks after the first operation. Note: RGI in the WJC transplanted discs (TS group) was significantly higher than those of the discs in the FS
and DS groups at 8, 12, 18, and 24 weeks after the first operation. Each data point represents the mean and standard deviation of 18 samples
(*p < 0.05, n = 18)
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discs in the TS group showed stronger signal intensity
than those in the DS and FS groups at 8 weeks, and this
result was sustained up to 24 weeks (p <0.05). No signifi-
cant differences were seen among the DS and FS groups.
The Pfirrmann classification analysis did not show disc
degeneration in all groups before the first operation
(Fig. 4a). The Pfirrmann classification in the TS group
was significantly higher compared with the CS group
(p <0.01), but significantly lower compared with the DS
and FS groups at 24 weeks (p <0.01) (Fig. 4b). Together,
these results indicated that the NP signal intensity consid-
erably decreased at 4 weeks after the second operation,
but the WJC transplantation reduced the decrease of the
NP signal intensity over the entire experimental period.
Results of biomechanical analysis
We further compared the biomechanical effect from the
three operated discs (DS, FS, and TS groups) and intactdisc (CS group). As shown in Fig. 5, the ROM of
flexion–extension and left–right rotation significantly
decreased in the DS or FS groups compared with the CS
group. The ROM of flexion–extension and left–right ro-
tation in the TS group showed significantly less reduc-
tion compared with the DS or FS groups. The ROM of
left–right bending, however, was not statistically differ-
ent between the four groups. The result showed that
transplantation of the WJCs into the IVD maintained
the ROM of flexion–extension and left–right rotation.
Macroscopic findings
As shown in Fig. 6, the macroscopic evaluation showed
that the NP in the CS group was hyaline and gelatinous
semi-fluid, and the NP in the TS group maintained a
relatively normal oval-shaped structure similar to that in
the CS group at 24 weeks. The DS and FS groups
showed disc space narrowing and dense scar tissues in
the NP. The discs of the TS group maintained the disc
Fig. 4 Analysis of signal changes in T2-weighted images using the Pfirrmann classification. a Discs showed no degeneration in all groups before
the first operation. b There was significantly lower grading of MRI scans in the TS group compared with DS and FS groups at 24 weeks after the
first operation (p <0.01)
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ever, the figure showed the gross appearance of the IVDs
from one animal only.
Survival of transplanted Wharton’s jelly cells in the
intervertebral discs
In this study, EGFP-labeled WJCs were transplanted into
the degenerate IVD in the TS group. One animal’s discs
were used to detect the survival of transplanted WJCs by
fluorescence microscopy. The other animals’ discs were
analyzed by immunohistochemistry. As shown in Fig. 7,
the fluorescence microscopy and immunohistochemical
micrographs confirmed the survival of the EGFP-labeled
WJCs in the discs of the TS group. No GFP-positive cells
were observed in the discs of the FS group.Fig. 5 Analysis of ROM of the discs. ROM of left–right bending was
not statistically different in the four groups. However, the ROM of
flexion–extension and left–right rotation in the TS group was larger
than that of the DS and FS groups at 24 weeks. *Significant
difference between the TS group and the DS or FS group, n = 18.
IVD intervertebral discResult of histological and immunohistochemical analysis
The beagle is a chondrodystrophic dog, and the IVD
degeneration occurs earlier and faster than that in non-
chondrodystrophic dogs. As shown in Figs. 8 and 9, early
degenerative changes of the IVD were detectable in the
histologic results which showed vacuolar degeneration
in all groups. The degenerative changes of the NP in the
DS and FS groups were more apparent than those in the
CS and TS groups. To further demonstrate the effect of
WJC transplantation on the disc matrix, the NP sections
were stained by SOX-9, type II collagen, and aggrecan
antibodies. As shown in Fig. 10, the immunohistochemi-
cal staining indicated that the NP in the TS and CS
groups was strongly positive for SOX-9, type II collagen,
and aggrecan. The staining intensity decreased or did
not show significant intensity in the NP of the DS and
FS groups. Immunohistochemical staining intensity ana-
lysis using Image-Pro Plus 6.0 showed that the staining
intensity of aggrecan, type II collagen, and SOX-9 was
significantly higher in the TS group than that in the DS
and FS groups (p <0.05).
Result of gene expression analysis
To confirm the effect of WJC transplantation on the
disc matrix, real-time PCR was used to measure the
levels of aggrecan, type II collagen, type I collagen, and
SOX-9 in the CS, DS, FS, and TS groups. As shown in
Fig. 11, the levels of aggrecan, type II collagen, and
SOX-9 mRNAs were decreased in the DS, FS, and TS
groups as compared with the CS group, while the type I
collagen expression was significantly increased in the
DS, FS, and TS groups (p <0.05). Importantly, we found
that the levels of aggrecan, type II collagen, and SOX-9
mRNAs were significantly higher in the TS group than
those in the DS and FS groups, and the type I collagen
Fig. 6 Typical macroscopic views of IVDs from the CS, DS, FS, and TS groups. Disc in the TS group shows an oval-shaped gel-like NP structure
similar to that of a disc from the CS group (black arrow). Discs from the DS and FS groups show loss of the normal NP structure (white
arrow) (bar = 5 mm)
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that in the DS and FS groups (p <0.05). Together, the
results show that WJC transplantation increased the
expression of aggrecan, type II collagen, and SOX-9.
Discussion
A number of reports have shown that transplantation of
adult MSCs including BMSCs [44], adipose-derived stem
cells (ADSCs) [50], synovial MSCs [51], and umbilical
cord blood MSCs [52] could repair the degenerate IVD
in vivo, but the effect and role of WJCs in the degenerativeFig. 7 Survival of the EGFP-labeled WJCs in the transplanted and control d
EGFP-labeled WJCs in the TS group disc. b Immunohistochemical microgra
disc. Note: no positive cell was observed in the FS group discIVDs in vivo have not been explored. By tracking the fate
of EGFP-tagged WJCs and observing the role of WJCs in
the degenerative IVDs in vivo, we firstly showed that WJC
transplantation could survive up to 20 weeks in the degen-
erate IVDs, and further demonstrated that WJCs could
decelerate the progressive degeneration of IVD in a canine
degeneration model.
The imaging outcomes and Pfirrmann classification
were two major parameters for evaluating IVD degener-
ation in the clinical. After WJC transplantation, we found
that the decline of %DHI in the TS group was decreasediscs. a Fluorescence microscopy demonstrated the survival of the
phs illustrate the survival of the EGFP-labeled WJCs in the TS group
Fig. 8 Histological image of the disc in the CS group. a Hematoxylin and eosin stain showed that the disc contains the nucleus pulposus (NP)
and transitional zone (TZ). b The TZ includes cartilage cells in the sections indicated by the gray arrow. c The NP includes vacuolar degeneration
notochordal cells in the sections indicated by the black arrow. Bar = 100 μm
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4 weeks. On T2-weighted imaging, the NP in the TS
group showed higher RGI than that in the DS and FS
groups. We also used Pfirrmann classification to assess
the signal intensity of T2-weighted images on MRI. The
TS group showed a significantly lower Pfirrmann grading
compared with the DS and FS groups at 24 weeks, and the
results were consistent with that of RGI. This observation
was consistent with Hiyama et al.’s study [44]. TheyFig. 9 Typical histological images of the NP in four groups. The paraffin se
micrographs illustrate the typical images of the NP sections from the WJC
groups), and intact NP group (CS group) (bar = 100 μm)showed that the disc regeneration was identified on radio-
logical and MRI scans after transplantation at 4 weeks
after induction of degeneration. However, in the study by
Chun et al. [50] there were no signal changes in the disc
space after transplantation of ADSCs. The reason for this
might be that the researchers transplanted the ADSCs at
19 weeks after induction of degeneration. The degener-
ation of discs was so severe that few ADSCs survived in
the discs, and the regeneration might not be apparent byctions of the NP tissues were stained by hematoxylin and eosin. These
transplanted group (TS group), degenerated control groups (DS and FS
Fig. 10 Typical immunohistochemical images. The immunohistochemical micrographs illustrate the typical images of the NP sections which were
stained by an antibody against SRY-box 9 (SOX-9), aggrecan (ACN), and type II collagen (Col II). Staining of the NP for SOX-9, aggrecan, and type II
collagen for the CS and TS groups was stronger than that for the DS and FS groups
Fig. 11 Real-time PCR analysis. Real-time PCR was used to analyze the
levels of the disc matrix components aggrecan, type II collagen, type I
collagen, and SOX-9 mRNAs in the disc tissues from the CS, DS, FS,
and TS groups. Expression was normalized to the average of the
housekeeping gene (glyceraldehyde-3-phosphate dehydrogenase)
and the DS group. The results showed that aggrecan, type II collagen,
and SOX-9 mRNA expression markedly increased in discs from the TS
group compared with the DS and FS groups. *Statistical significance
(p <0.05) from the DS and FS groups. SOX-9 SRY-box 9
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treatment might be more effective in the early period of
IVD degeneration.
To determine whether xenogeneic WJCs could survive
in the IVDs, the EGFP-labeled WJCs were transplanted
into canine degenerate IVDs. At 20 weeks after transplant-
ation, the viable EGFP-labeled WJCs could be detected in
the IVDs of one animal by fluorescence microscopy and
in all IVDs of the TS group by immunohistochemistry.
This suggested that WJCs could survive up to 20 weeks in
the degenerate IVDs. Similar research findings have also
been obtained in porcine [53], rabbit [50], and rat [54]
models using xenogeneic BMSCs, synovial MSCs, and
ADSCs. In the study by Henrikkson et al. [53], MSCs were
detected by immunohistochemical staining of mouse anti-
human nuclei (HNA) at 6 months after transplantation to
the porcine discs and were confirmed to differentiate to-
ward chondrocyte-like cells by detecting human specific
collagen II, aggrecan, and SOX9 using human TaqMan
Gene Expression Assays. In the present study, we used
EGFP for tracking of transplanted WJCs that were also
used in the study by Miyamoto et al. [51]. In this study,
human WJCs could survive at least 20 weeks in a canine
model of IVD degeneration. We believe there are two
reasons for this survival: WJCs are immunologically privi-
leged and can be used for allogenic and xenogeneic trans-
plantation; and the NP is absent of vasculature and cannot
Zhang et al. Stem Cell Research & Therapy  (2015) 6:154 Page 12 of 15generate an immune response. So the “immunologically
privileged” environment of the avascular NP might ac-
count for long-term viability of xenogeneic stem cells.
Different from the research by Henrikkson et al. [53],
the primers used in real-time PCR and the primary anti-
bodies used in immunohistochemistry were not canine
or human specific in our study. The real-time PCR and
immunohistochemistry results demonstrated that WJC
transplantation significantly increased the expression of
disc ECM components such as aggrecan and type II
collagen compared with the DS and FS groups. These
results suggested that the transplanted WJCs could es-
tablish a matrix-producing function in the degenerate
IVDs. This was in keeping with many previous studies
[16, 50, 55–58] which showed that transplantation of
MSCs seems to exert corrective, therapeutic effects on
the degenerate IVD even though there was no sufficient
evidence to confirm the transplanted WJCs differentiat-
ing into NP cells. Furthermore, our previous studies
demonstrated that the WJCs could differentiate into NP-
like cells by coculturing with the disc NP cells in vitro
[42]. Therefore, it could be deduced that the trans-
planted WJCs and their progeny perhaps differentiated
into NP-like cells in the stromal microenvironment of
discs in vivo. Certainly this in vivo differentiate research
will continue to provide a powerful tool to investigate
the biological behavior and function of WJCs.
A number of studies have shown that degradative en-
zymes were highly produced by NP cells in degenerate
IVDs [59, 60]. Matrix metalloproteinase (MMP) gene
expression, however, could be downregulated in NP
cells after coculture with MSCs [51]. Another possible
mechanism of delaying IVD degeneration might there-
fore be that intradiscal transplantation of WJCs affected
the endogenous NP cells by inhibiting the expressions
of MMP genes or upregulating the expressions of SOX-
9 and ECM genes, as shown by the results of genetic
evaluation in the present study.
Some species such as rabbits [50], rats [58], pigs [53],
and beagles [44] have been used as animal models for
cell transplantation studying in IVD degeneration [61,
62]. In this study, beagles were used as an animal model
because the beagle model of disc degeneration was
closer to human morphology and was of the same sta-
tus in human [44, 63]. To eliminate individual differ-
ences such as weight, infection status, activity level, and
immune competence, we chose the experimental model
in which control and experimental segments were
present in the same animal. We fixed assignment of
discs to a specific group, and we believed that lumbar
biomechanical stress might not have significant differ-
ences from level to level owing to the fact that beagles
couldn't walk upright. However, randomization of the
disc levels would be the best study design. The discs ofbeagles are prone to degeneration at an earlier age,
which might affect individual IVDs to a different extent.
Thus, there might be potential bias in the study. The
beagle was a chondrodystrophic breed, and the NP of
young beagle consisted mainly of notochordal cells and
was gradually replaced by chondrocyte-like cells with
aging. Gillett et al. [64] showed that the NP of 2-year-
old beagles had vacuolar degenerative notochordal cells
and cloning of cartilage in the transitional zone (TZ).
Consistent with the study, we also found vacuolar degen-
erative notochordal cells in the NP and cloning of cartil-
age in the TZ in 1.5-year-old beagles. Moreover, the
degeneration of discs in the CS and TS groups was slightly
higher than that of discs in the DS and FS groups.
There are many methods including mechanical com-
pression, mechanical instability, structural injury, and
chemical injury to establish an animal model of IVD
degeneration [65]. In this study, partial aspiration of
the NP was used to establish an animal model of de-
generation. However, there were shortcomings to this
method, because this IVD degeneration model might
not truly represent human disc degeneration. In human
IVD, the balance between matrix synthesis and degrad-
ation was destructed with aging which induced progres-
sive degeneration and pathologic alteration of IVD, and
this was related to the bad microenvironment of low
pH, reduction in nutrients, and increased inflammatory
cytokines. In this animal model, however, the IVD de-
generation was caused by aspiration of NP tissues,
which decreased the number of NP cells and resulted
in decrease in proteoglycan content and disc height. Al-
though this was a shortcoming of this model, there was
no suitable animal model that could completely mimic
human IVD degeneration up to now [56]. For this rea-
son, we chose the aspiration-induced model of degener-
ation in this study. Moreover, this model had been used
in many cell transplantation studies [9, 44, 56, 57, 66].
In our study, the NP of the DS group was observed to
undergo degeneration by the gradual decrease of %DHI
and RGI from the results of radiological and MRI analysis,
so the degeneration was successfully induced in this ani-
mal model.
Many studies have reported that the transplantation of
MSCs could decelerate the process of disc degeneration
in an animal model [44]. The safety and effectiveness of
BMSC and WJC transplantation have been confirmed in
clinical research [67, 68]. What are the advantages of
using WJCs in the clinical setting compared with adult
MSCs? First, WJCs express HLA class I and do not
express HLA class II surface markers, and are immune
suppressive in mixed lymphocyte assays and inhibit T-
cell proliferation [69–73]. Moreover, like other adult
MSCs, WJCs are immunologically privileged, do not re-
quire tissue matching, and can be tolerated in allogeneic
Zhang et al. Stem Cell Research & Therapy  (2015) 6:154 Page 13 of 15and xenogeneic transplantation [32] because any donor
can supply the cells to any other patient without need
for immunosuppressant drugs [70]. Second, WJCs are
perinatal stem cell sources which represent a bridge be-
tween embryonic and adult stem cells, and have great
potential to serve as a useful stem cell source to treat
various diseases in the clinics [74]. Third, the umbilical
cord is abundant and easy to obtain. Use of the human
umbilical cord tissues involves mild ethical and less reli-
gious controversies [31, 75]. This source of stem cells
allows the rapid initial isolation of large numbers of
cells, avoiding the necessity of extensive multiplication
and potential epigenetic damage [76]. Fourth, compared
with other adult MSCs, WJCs have shorter doubling
times, and greater ex-vivo expansion capabilities and
numbers of passages to senescence [77]. Finally, cells
derived from Wharton’s jelly have a higher frequency of
colony-forming unit fibroblasts as compared with that
of BMSCs [78, 79]. Taken together, these studies sug-
gested that the WJCs could serve as a valuable cell
resource instead of other original MSCs. The results of
our study also suggest that WJCs might be a better
candidate for a cell-based treatment for degenerative
disc disease in clinical application.
Conclusions
Our study demonstrated that WJC transplantation main-
tained the disc height and T2-weighted signal intensity,
and promoted the disc matrix formation of aggrecan and
type II collagen in degenerate IVDs. WJCs are a potential
cell source for disc regeneration and have important value
in the treatment of degenerative disc disease.
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